The results showed that ECM1 can rescue the expression levels of p-FAK, p-AKT, and p-GSK3β in PARP inhibitor-resistant ovarian cancer cells (Supplementary Figure 2G). The gene discussed is GSK3B; the disease is ovarian cancer.